Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Five Clinical Trial Hits Of 2022

Jan 23 2023

• By Alaric DeArment

• Source: Shutterstock

Related Content

US FDA’s Post-Aduhelm Reforms Include Updated Alzheimer’s Development Guidance, Record-Keeping On Sponsor Meetings

Jan 03 2023

Tirzepatide’s Glowing Obesity Data Steal Show On Lilly’s Earnings Call

Apr 28 2022

Pfizer Buys Arena For $6.7bn In Bid To Diversify In Inflammation & Immunology

Dec 13 2021

Roche Has Eylea In Its Sights After Farcimab Approval

Jan 31 2022

Eisai/Biogen’s Leqembi Will Launch Below Aduhelm At $26,500 Per Year

Jan 06 2023

BioMarin Hopes A Single Warranty Will Make Gene Therapy Reimbursement Simpler

Jan 10 2023

Biogen Weighs Aduhelm Lessons Ahead Of Lecanemab Launch

Oct 25 2022

Lilly Settles On Rolling Submission For Tirzepatide In Obesity

Oct 07 2022

Rising Tide Lifts Many Ships In Wake Of Eisai/Biogen’s Lecanemab Readout

Sep 28 2022

A Banner Moment For Alzheimer's Positions Eisai/Biogen At The Head Of The Pack

Sep 28 2022

High-Dose Eylea’s Improved Durability Could Protect Regeneron’s Market Share

Sep 09 2022

Etrasimod Results Justify Pfizer’s Leap Of Faith In Arena Buyout

May 24 2022

Lilly’s Mounjaro Diabetes Approval Is First Challenge To Novo’s GLP-1 Franchise

May 13 2022

Novo Nordisk’s Concizumab Could Be First In New Class For Hemophilia

Jul 11 2022

Lecanemab Set A New Bar In Alzheimer’s, Now Many Drugs Are Seeking To Raise It

Dec 16 2022

Novo Nordisk Halts Phase III Concizumab Hemophilia Trials After Three Thrombotic Events

Mar 17 2020

Related Companies

Eisai Co., Ltd.

Biogen, Inc.

Pfizer Inc.

Regeneron Pharmaceuticals, Inc.

Roche Holding AG

Eli Lilly and Company

Novo Nordisk A/S

Bayer AG

Baxalta Incorporated

uniQure N.V.

CSL Limited

BioMarin Pharmaceutical Inc.

Additional Topics

Clinical Trials Business Strategies Research & Development Scrip Perspectives BioPharmaceutical

More from Scrip Perspectives

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window